MedTrace Logo

Prevention of Bleeding in Patient With Cirrhosis Undergoing Dental Extraction

NCT00816127 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 36

Last updated 2009-01-01

No results posted yet for this study

Summary

The purpose of this study is to investigate how effective and cost saving 1-deamino-8-D-arginine vasopressin (desmopressin, DDAVP) is as opposed to the transfusion of blood products in preventing bleeding after teeth extraction in persons with severe liver disease being evaluated for liver transplant.

Conditions

Interventions

DRUG

Desmopressin

intranasal desmopressin (300μg)

BIOLOGICAL

blood transfusion

fresh frozen plasma 10ml/kg and/or 1 unit of single donor platelets

Sponsors & Collaborators

Principal Investigators

  • Thomas D. Schiano, MD · Icahn School of Medicine at Mount Sinai

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2003-10-31
Primary Completion
2007-05-31
Completion
2007-05-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00816127 on ClinicalTrials.gov